Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	subject type
Reversed phase NEGATIVE ION MODE	LYSINE (CAS# 56-87-1); (M-H)-	1569	Peak area	Healthy control
Reversed phase NEGATIVE ION MODE	LYSINE (CAS# 56-87-1); (M-H)-	10844	Peak area	Severe disease
Reversed phase NEGATIVE ION MODE	LYSINE (CAS# 56-87-1); (M-H)-	11894	Peak area	Mild disease
Reversed phase NEGATIVE ION MODE	LYSINE (CAS# 56-87-1); (M-H)-	12851	Peak area	Severe disease
Reversed phase NEGATIVE ION MODE	LYSINE (CAS# 56-87-1); (M-H)-	15303	Peak area	Mild disease
Reversed phase NEGATIVE ION MODE	LYSINE (CAS# 56-87-1); (M-H)-	15399	Peak area	Mild disease
Reversed phase NEGATIVE ION MODE	LYSINE (CAS# 56-87-1); (M-H)-	17006	Peak area	Healthy control
Reversed phase NEGATIVE ION MODE	LYSINE (CAS# 56-87-1); (M-H)-	17999	Peak area	Severe disease
Reversed phase NEGATIVE ION MODE	LYSINE (CAS# 56-87-1); (M-H)-	18033	Peak area	Mild disease
Reversed phase NEGATIVE ION MODE	LYSINE (CAS# 56-87-1); (M-H)-	18392	Peak area	Severe disease
Reversed phase NEGATIVE ION MODE	LYSINE (CAS# 56-87-1); (M-H)-	18648	Peak area	Healthy control
Reversed phase NEGATIVE ION MODE	LYSINE (CAS# 56-87-1); (M-H)-	19277	Peak area	Healthy control
Reversed phase NEGATIVE ION MODE	LYSINE (CAS# 56-87-1); (M-H)-	20973	Peak area	Healthy control
Reversed phase NEGATIVE ION MODE	LYSINE (CAS# 56-87-1); (M-H)-	22595	Peak area	Healthy control
Reversed phase NEGATIVE ION MODE	LYSINE (CAS# 56-87-1); (M-H)-		Peak area	Mild disease
Reversed phase NEGATIVE ION MODE	LYSINE (CAS# 56-87-1); (M-H)-		Peak area	Severe disease
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	51915	Peak area	Severe disease
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	60987	Peak area	Mild disease
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	61708	Peak area	Mild disease
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	68782	Peak area	Mild disease
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	77010	Peak area	Mild disease
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	111916	Peak area	Severe disease
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	119397	Peak area	Healthy control
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	120498	Peak area	Healthy control
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	123808	Peak area	Severe disease
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	131021	Peak area	Healthy control
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	146622	Peak area	Healthy control
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	154241	Peak area	Healthy control
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+		Peak area	Healthy control
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+		Peak area	Mild disease
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+		Peak area	Severe disease
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	2994	Peak area	Severe disease
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	7299	Peak area	Severe disease
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+		Peak area	Healthy control
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+		Peak area	Mild disease
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+		Peak area	Severe disease